Sensorion Publishes Results of Combined General Meeting Resolutions
businesswire.com
news
2022-06-01 00:00:00

June 01, 2022 01:30 AM Eastern Daylight Time MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News:

Sensorion (FR0012596468 â€“ ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces today the results of resolutions presented at its Combined General Meeting (CGM), held in-person, on May 31, 2022 and made them available on the dedicated section of its website.
